BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,128,151 | +459.0% | 24,730 | +399.8% | 0.02% | +400.0% |
| Q1 2023 | $201,831 | -39.6% | 4,948 | -24.2% | 0.01% | -44.4% |
| Q4 2022 | $334,425 | -21.3% | 6,530 | -17.2% | 0.01% | -30.8% |
| Q3 2022 | $425,000 | -29.6% | 7,886 | -16.0% | 0.01% | -48.0% |
| Q2 2022 | $604,000 | -15.2% | 9,390 | +2.3% | 0.02% | +8.7% |
| Q1 2022 | $712,000 | +18.1% | 9,175 | +30.8% | 0.02% | +35.3% |
| Q4 2021 | $603,000 | +7.1% | 7,014 | +0.4% | 0.02% | -5.6% |
| Q3 2021 | $563,000 | +3.3% | 6,988 | +3.4% | 0.02% | 0.0% |
| Q2 2021 | $545,000 | -14.8% | 6,761 | -10.8% | 0.02% | -21.7% |
| Q1 2021 | $640,000 | +16.8% | 7,580 | +11.0% | 0.02% | -20.7% |
| Q4 2020 | $548,000 | +54.8% | 6,826 | +55.3% | 0.03% | +52.6% |
| Q3 2020 | $354,000 | -9.9% | 4,394 | -3.5% | 0.02% | -26.9% |
| Q2 2020 | $393,000 | +32.8% | 4,554 | +25.0% | 0.03% | +4.0% |
| Q1 2020 | $296,000 | +33.3% | 3,642 | +37.6% | 0.02% | +31.6% |
| Q4 2019 | $222,000 | -15.9% | 2,647 | -12.1% | 0.02% | -26.9% |
| Q3 2019 | $264,000 | -19.5% | 3,011 | -25.2% | 0.03% | -36.6% |
| Q1 2019 | $328,000 | +48.4% | 4,026 | +20.4% | 0.04% | +32.3% |
| Q4 2018 | $221,000 | -14.7% | 3,343 | +0.0% | 0.03% | 0.0% |
| Q3 2018 | $259,000 | +28.9% | 3,342 | -31.4% | 0.03% | -32.6% |
| Q1 2016 | $201,000 | +415.4% | 4,874 | +811.0% | 0.05% | +4500.0% |
| Q4 2014 | $39,000 | – | 535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |